Bristol-Myers Squibb Company (BMY)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 78.22 |
| Open | 78.27 |
| Bid | 76.50 x 1400 |
| Ask | 76.53 x 800 |
| Day's Range | 76.84 - 78.46 |
| 52 Week Range | 53.22 - 78.47 |
| Volume | |
| Avg. Volume | 15,517,026 |
| Market Cap | 170.957B |
| Beta (5Y Monthly) | 0.54 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.16 (2.85%) |
| Ex-Dividend Date | Mar 31, 2022 |
| 1y Target Est | N/A |
- Zacks
Biotech Stock Roundup: BBIO Up on BMY Deal, GILD & CMRX Offer Updates
Regulatory updates and acquisition news from Bristol Myers' (BMY) and BridgeBio Pharma (BBIO) are a few key highlights from the biotech sector during the past week.
- Zacks
Bristol Myers (BMY) Phase III CheckMate -901 Study Disappoints
Bristol Myers (BMY) phase III CheckMate -901 study fails to meet the primary endpoint of overall survival in patients with untreated unresectable or metastatic urothelial cancer.
- Zacks
BridgeBio (BBIO) Up on Deal With BMY for SHP2 Inhibitor
BridgeBio (BBIO) forms an exclusive partnership with Bristol Myers (BMY) to develop and commercialize its SHP2 inhibitor.
© 2022 Yahoo. All rights reserved.
